Skip to content

Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

A Comparative Study of Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream, for the Treatment of Photodamage

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00647556
Enrollment
30
Registered
2008-03-31
Start date
2008-04-30
Completion date
2010-01-31
Last updated
2022-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Photoaging

Brief summary

The primary purpose of this study is to compare the efficacy of adapalene (Differin®) gel 0.3% and tretinoin 0.05% emollient cream for the treatment of signs of photodamage, with tolerability assessment as a secondary objective.

Detailed description

Same as above.

Interventions

applied topically once daily in the evening

DRUGtretinoin 0.05% emollient cream

applied topically once daily in the evening

Sponsors

Galderma R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or Female aged 40 years of age and older with Fitzpatrick skin types I through III * Clinically moderate to severe photodamage

Exclusion criteria

* Subjects with history of laser resurfacing, dermabrasion, medium or deep chemical peel of the face * Subjects with diagnosis of skin cancer within 3 months of study entry * Subjects who have had superficial chemical peels, exfoliation or microdermabrasion of the face within 3 months of study entry * Subjects who have had botulinum toxin for facial rejuvenation within 6 months of study entry and are unwilling to refrain from botulinum toxin treatments during the study

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Overall Integrated Assessment of Photodamage at Week 24baseline to week 24Number of participants who improved (a decrease by at least one point) in Overall Integrated Assessment of Photodamage from baseline to week 24. Overall Integrated Assessment of Photodamage is a scale from 0 - 5 (0 = None, 1 = Minimal, 2 = Mild, 3 - Moderate, 4 = Severe and 5 = Very Severe) with 0 being best and 5 being worst.

Secondary

MeasureTime frameDescription
Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24baseline, week 12 and week 24Number of participants in each category of the Photonumeric Scale for the Assessment of Photodamage from baseline to week 12 and baseline to week 24. Photonumeric Scale consisted of 9 categories (Fine Wrinkling, Mottled Pigmentation, Irregular Depigmentation, Lentigines, Coarse Wrinkling, Elastosis, Tactile Roughness, Telangiectasia, and Actinic Keratosis. These were evaluated on a scale from 0 - 4 (0 = None, 1 = Minimal, 2 = Mild, 3 = Moderate and 4 = Severe) with 0 being best and 4 being worst.
Number of Participants Who Improved (a Decrease of at Least One Point) in Overall Integrated Assessment of Photodamage From Baseline to Week 12.baseline to week 12Number of participants who improved in Overall Integrated Assessment of Photodamage from baseline to week 12. Overall Integrated Assessment of Photodamage was evaluated on a scale from 0 - 5 (0 = None, 1 = Minimal, 2 = Mild, 3 = Moderate 4 = Severe and 5 = Very Severe) with 0 being best and 5 being worst.
Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 and week 24Number of participants in each category of the Subject Evaluation of Improvement at week 12 and week 24. Subject Evaluation of Improvement was evaluated on a scale from 0 - 6 (0 = Complete Improvement, 1 = Almost (\ 90%) Improvement, 2 = Marked (\ 75%) Improvement, 3 = Moderate (\ 50%) Improvement, 4 = Slight (\ 25%) Improvement, 5 = No Change, 6 = Worse) with 0 being best and 6 being worst.
Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 and week 24Number of participants in each category of the Investigator Evaluation of Global Response (Improvement) at week 12 and week 24. Investigator Evaluation of Global Response (Improvement) is evaluated on a scale from 0 - 6 (0 = Complete Response, 1 = Almost Complete (\ 90%) Response, 2 = Marked (\ 75%) Response, 3 = Moderate (\ 50%) Response, 4 = Slight (\ 25%) Response, 5 = No Response and 6 = Worsening) with 0 being best and 6 being worst.

Countries

United States

Participant flow

Recruitment details

Dates of recruitment period: First subject was enrolled on June 17, 2008 and the last subject was enrolled on July 24, 2009.

Pre-assignment details

Wash-out period at baseline: 2 wks topical alpha-hydroxy, glycolic, salicylic, lactic, & beta-hydroxy acids, topical vitamin A, ascorbic acid, vitamin E, corticosteroids on face; 4 wks systemic corticosteroids; 3 mos topical retinoids, superficial chemical peels/exfoliation/microdermabrasion; 6 mos botulinum toxin on the face; 1 yr oral retinoids.

Participants by arm

ArmCount
Differin® Gel, 0.3%
adapalene gel 0.3% - apply once daily in the evening for 24 weeks
15
Tretinoin Emollient Cream
Tretinoin Emollient Cream 0.05% - apply topically once daily in the evening for 24 weeks
15
Total30

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event01
Overall StudyLost to Follow-up10
Overall StudyProtocol Violation01
Overall StudySurgery for pre-existing neck pain10
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicDifferin® Gel, 0.3%Tretinoin Emollient CreamTotal
Age, Continuous60.9 years
STANDARD_DEVIATION 11.37
61.3 years
STANDARD_DEVIATION 9.58
61.1 years
STANDARD_DEVIATION 10.33
Sex: Female, Male
Female
10 Participants12 Participants22 Participants
Sex: Female, Male
Male
5 Participants3 Participants8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
7 / 1514 / 15
serious
Total, serious adverse events
0 / 150 / 15

Outcome results

Primary

Change From Baseline in Overall Integrated Assessment of Photodamage at Week 24

Number of participants who improved (a decrease by at least one point) in Overall Integrated Assessment of Photodamage from baseline to week 24. Overall Integrated Assessment of Photodamage is a scale from 0 - 5 (0 = None, 1 = Minimal, 2 = Mild, 3 - Moderate, 4 = Severe and 5 = Very Severe) with 0 being best and 5 being worst.

Time frame: baseline to week 24

Population: ITT (Intent to Treat), LOCF (Last Observation Carried Forward)

ArmMeasureValue (NUMBER)
Differin® Gel, 0.3%Change From Baseline in Overall Integrated Assessment of Photodamage at Week 246 participants
Tretinoin Emollient CreamChange From Baseline in Overall Integrated Assessment of Photodamage at Week 2410 participants
Secondary

Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24

Number of participants in each category of the Investigator Evaluation of Global Response (Improvement) at week 12 and week 24. Investigator Evaluation of Global Response (Improvement) is evaluated on a scale from 0 - 6 (0 = Complete Response, 1 = Almost Complete (\ 90%) Response, 2 = Marked (\ 75%) Response, 3 = Moderate (\ 50%) Response, 4 = Slight (\ 25%) Response, 5 = No Response and 6 = Worsening) with 0 being best and 6 being worst.

Time frame: week 12 and week 24

Population: ITT (Intent to Treat), LOCF (Last Observation Carried Forward)

ArmMeasureGroupValue (NUMBER)
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Missing3 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Moderate Response2 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Complete Response0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Almost Complete Response0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Almost Complete Response0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Slight Response9 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Marked Response2 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Complete Response0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Moderate Response2 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 No Response1 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 No Response2 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Marked Response0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Worsening0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Worsening0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Missing3 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Slight Response6 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Missing0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Complete Response0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Almost Complete Response0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Marked Response1 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Moderate Response4 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Slight Response6 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 No Response2 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Worsening0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 12 Missing2 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Complete Response0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Almost Complete Response0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Marked Response0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Slight Response4 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 No Response3 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Worsening0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24week 24 Moderate Response8 participants
Secondary

Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24

Number of participants in each category of the Subject Evaluation of Improvement at week 12 and week 24. Subject Evaluation of Improvement was evaluated on a scale from 0 - 6 (0 = Complete Improvement, 1 = Almost (\ 90%) Improvement, 2 = Marked (\ 75%) Improvement, 3 = Moderate (\ 50%) Improvement, 4 = Slight (\ 25%) Improvement, 5 = No Change, 6 = Worse) with 0 being best and 6 being worst.

Time frame: week 12 and week 24

Population: ITT (Intent to Treat; LOCF (Last Observation Carried Forward)

ArmMeasureGroupValue (NUMBER)
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Moderate Improvement4 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Moderate Improvement4 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Missing3 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Slight Improvement4 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 No Change0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 No Change0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Complete Improvement0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Worse0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Slight Improvement3 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Missing3 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Almost Complete Improvement0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Complete Improvement0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Worse0 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Almost Complete Improvement3 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Marked Improvement4 participants
Differin® Gel, 0.3%Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Marked Improvement2 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Marked Improvement2 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Moderate Improvement4 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Slight Improvement1 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 No Change5 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Worse0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Missing0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Complete Improvement0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Almost Complete Improvement0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Marked Improvement4 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Moderate Improvement5 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Slight Improvement4 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 No Change2 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Worse0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 12 Missing2 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Complete Improvement0 participants
Tretinoin Emollient CreamNumber of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24week 24 Almost Complete Improvement1 participants
Secondary

Number of Participants Who Improved (a Decrease of at Least One Point) in Overall Integrated Assessment of Photodamage From Baseline to Week 12.

Number of participants who improved in Overall Integrated Assessment of Photodamage from baseline to week 12. Overall Integrated Assessment of Photodamage was evaluated on a scale from 0 - 5 (0 = None, 1 = Minimal, 2 = Mild, 3 = Moderate 4 = Severe and 5 = Very Severe) with 0 being best and 5 being worst.

Time frame: baseline to week 12

Population: ITT (Intent to Treat), LOCF (Last Observation Carried Forward)

ArmMeasureValue (NUMBER)
Differin® Gel, 0.3%Number of Participants Who Improved (a Decrease of at Least One Point) in Overall Integrated Assessment of Photodamage From Baseline to Week 12.6 participants
Tretinoin Emollient CreamNumber of Participants Who Improved (a Decrease of at Least One Point) in Overall Integrated Assessment of Photodamage From Baseline to Week 12.4 participants
Secondary

Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24

Number of participants in each category of the Photonumeric Scale for the Assessment of Photodamage from baseline to week 12 and baseline to week 24. Photonumeric Scale consisted of 9 categories (Fine Wrinkling, Mottled Pigmentation, Irregular Depigmentation, Lentigines, Coarse Wrinkling, Elastosis, Tactile Roughness, Telangiectasia, and Actinic Keratosis. These were evaluated on a scale from 0 - 4 (0 = None, 1 = Minimal, 2 = Mild, 3 = Moderate and 4 = Severe) with 0 being best and 4 being worst.

Time frame: baseline, week 12 and week 24

Population: ITT (Intent to Treat), LOCF (Last Observation Carried Forward)

ArmMeasureGroupValue (NUMBER)
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline Mild (2)3 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline Mild (2)10 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 Moderate (3)4 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 Moderate (3)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline Minimal (1)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline Mild (2)5 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline Moderate (3)7 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 Minimal (1)3 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 Mild (2)7 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 Moderate (3)5 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 None (0)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 Minimal (1)3 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 Mild (2)7 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 Moderate (3)4 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 Minimal (1)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 Mild (2)9 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 Minimal (1)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 Mild (2)10 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 Moderate (3)3 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline Minimal (1)7 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline Mild (2)3 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline Moderate (3)4 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 Minimal (1)9 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 Mild (2)5 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 Moderate (3)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 Minimal (1)10 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 Mild (2)4 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline Minimal (1)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 Moderate (3)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline Moderate (3)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline Severe (4)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 Minimal (1)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 Mild (2)9 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 Moderate (3)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 Severe (4)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 Minimal (1)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 Mild (2)8 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 Moderate (3)3 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 Severe (4)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline Minimal (1)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline Mild (2)7 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline Moderate (3)6 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline Minimal (1)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline Mild (2)6 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline Moderate (3)9 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 Minimal (1)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 Mild (2)4 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 Moderate (3)8 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 Minimal (1)3 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 Mild (2)4 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 Moderate (3)7 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline None (0)8 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline Minimal (1)5 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 Moderate (3)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline Mild (2)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline Moderate (3)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 None (0)9 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 Minimal (1)5 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 Mild (2)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 None (0)12 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 Minimal (1)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 Mild (2)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 Minimal (1)6 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 Mild (2)6 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 Moderate (3)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 None (0)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 Minimal (1)7 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 Mild (2)5 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 Moderate (3)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline Minimal (1)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline Moderate (3)12 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 Minimal (1)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 Mild (2)9 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 Moderate (3)5 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 Minimal (1)2 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 Mild (2)8 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 Moderate (3)5 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline Minimal (1)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline Mild (2)7 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline Moderate (3)8 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 None (0)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 Minimal (1)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 Mild (2)7 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 Moderate (3)6 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 None (0)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 Minimal (1)3 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 Mild (2)6 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 Moderate (3)4 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 Severe (4)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline None (0)1 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline Minimal (1)5 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline Mild (2)6 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline Moderate (3)3 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline Severe (4)0 participants
Differin® Gel, 0.3%Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 None (0)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 Minimal (1)10 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline Moderate (3)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline Minimal (1)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 Minimal (1)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline Minimal (1)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline Severe (4)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 Minimal (1)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline Moderate (3)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline Minimal (1)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 Mild (2)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 Moderate (3)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 None (0)8 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 Minimal (1)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 Moderate (3)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline Mild (2)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 Mild (2)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline Minimal (1)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline Mild (2)9 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 Moderate (3)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline Moderate (3)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline Moderate (3)11 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines baseline Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 Minimal (1)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 Mild (2)9 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline Severe (4)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 12 Moderate (3)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 Minimal (1)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 Mild (2)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 Mild (2)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 Minimal (1)7 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 Mild (2)7 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 Moderate (3)6 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 Moderate (3)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Lentigines week 24 Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 24 Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 Minimal (1)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 Minimal (1)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 Mild (2)6 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 Moderate (3)7 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline None (0)9 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline Minimal (1)7 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 Mild (2)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 Mild (2)8 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 Minimal (1)7 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 Moderate (3)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline Mild (2)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 24 Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline None (0)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 Moderate (3)9 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline Minimal (1)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline Moderate (3)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline Mild (2)7 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 Moderate (3)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline Moderate (3)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis baseline Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness baseline Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 12 Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 None (0)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 None (0)9 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 Minimal (1)6 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 Mild (2)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 Mild (2)7 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 Minimal (1)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 Moderate (3)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 None (0)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 12 Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline Moderate (3)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 None (0)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 12 Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 Minimal (1)11 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 Minimal (1)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 Mild (2)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 Moderate (3)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 Minimal (1)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline Minimal (1)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline Mild (2)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 Mild (2)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline Moderate (3)7 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 Mild (2)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling baseline Severe (4)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Actinic keratosis week 24 Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 None (0)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 Mild (2)8 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 Moderate (3)7 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 Moderate (3)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 Minimal (1)9 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 12 Severe (4)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 12 Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 Mild (2)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 Minimal (1)2 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling week 24 Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 Mild (2)6 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 Moderate (3)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 Moderate (3)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline Mild (2)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Coarse wrinkling week 24 Severe (4)3 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 12 Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 None (0)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline Mild (2)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation week 24 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline Moderate (3)8 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 Minimal (1)9 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis baseline Severe (4)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline Minimal (1)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Elastosis week 12 None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 Mild (2)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 Moderate (3)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation baseline None (0)1 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Tactile Roughness week 24 Severe (4)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Irregular depigmentation week 24 Moderate (3)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Mottled pigmentation baseline Mild (2)8 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline Minimal (1)4 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Fine wrinkling baseline None (0)0 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia baseline Mild (2)5 participants
Tretinoin Emollient CreamPhotonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24Telangiectasia week 12 None (0)0 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026